NCT03599414View on ClinicalTrials.gov

CASPA: CArdiac Sarcoidosis in PApworth

CompletedOBSERVATIONAL
Enrollment

104

Participants

Timeline

Start Date

June 29, 2017

Primary Completion Date

March 24, 2020

Study Completion Date

March 8, 2023

Conditions
Interstitial Lung DiseasePulmonary SarcoidosisCardiac Sarcoidosis
Trial Locations (1)

CB23 3RE

Royal Papworth Hospital, Papworth Everard

All Listed Sponsors
collaborator

Imperial College London

OTHER

lead

Papworth Hospital NHS Foundation Trust

OTHER_GOV

NCT03599414 - CASPA: CArdiac Sarcoidosis in PApworth | Biotech Hunter | Biotech Hunter